Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
1,962.01
1,680.81
1,719.01
1,582.81
1,193.35
1,015.86
657.44
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,962.01
1,680.81
1,719.01
1,582.81
1,193.35
1,015.86
657.44
Raw Material Cost
1,396.08
1,082.62
1,029.74
907.54
647.49
569.15
333.24
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
541.10
452.77
490.91
441.95
280.99
204.09
146.66
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
34.59
62.28
68.20
46.64
10.69
0.71
3.87
Selling and Distribution Expenses
240.87
217.75
238.53
230.41
164.21
149.60
95.42
Other Expenses
-47.56
-41.81
-40.32
-33.32
-18.90
-12.18
-8.78
Total Expenditure (Excl Depreciation)
1,737.09
1,397.30
1,424.23
1,293.39
914.41
801.78
491.41
Operating Profit (PBDIT) excl Other Income
224.89999999999998
283.5
294.8
289.40000000000003
278.9
214.1
166
Other Income
54.34
85.61
64.78
94.86
251.79
-7.03
22.64
Operating Profit (PBDIT)
386.59
442.74
445.58
469.54
580.06
230.97
206.84
Interest
34.59
62.28
68.20
46.64
10.69
0.71
3.87
Exceptional Items
0.70
7.97
-32.71
1.99
1.67
0.00
0.02
Gross Profit (PBDT)
565.93
598.19
689.27
675.27
545.86
446.72
324.20
Depreciation
144.10
139.15
121.58
94.47
58.82
26.19
22.49
Profit Before Tax
208.60
249.28
223.10
330.41
512.21
204.07
180.51
Tax
23.87
29.36
24.01
-2.63
4.00
20.30
20.28
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
183.74
219.54
197.36
314.22
486.56
184.21
152.07
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
183.74
219.54
197.36
314.22
486.56
184.21
152.07
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
-0.00
11.67
17.21
-0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
183.74
219.54
197.36
325.89
503.77
184.20
152.07
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
6,300.14
2,987.55
2,832.28
2,657.64
2,427.42
1,894.72
740.87
Earnings per share (EPS)
0.88
1.1
0.98
1.57
2.44
0.75
0.82
Diluted Earnings per share
0.88
1.1
0.98
1.57
2.44
0.75
0.82
Operating Profit Margin (Excl OI)
9.59%
12.97%
15.08%
17.7%
22.58%
20.85%
24.6%
Gross Profit Margin
17.98%
23.11%
20.05%
26.84%
47.85%
22.67%
30.88%
PAT Margin
9.36%
13.06%
11.48%
19.85%
40.77%
18.13%
23.13%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 16.73% vs -2.22% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is -16.31% vs 11.20% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is -6.94% vs -6.22% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is -44.46% vs -8.65% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has fallen from Dec 2024
Compare Annual Results Of PharmaBlock Sciences (Nanjing), Inc. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
1,962.01
0
1,962.01
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,962.01
0
1,962.01
Raw Material Cost
1,396.08
0
1,396.08
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
541.10
0
541.10
Power Cost
0
0
0.00
Manufacturing Expenses
34.59
0
34.59
Selling and Distribution Expenses
240.87
0
240.87
Other Expenses
-47.56
0.00
-47.56
Total Expenditure (Excl Depreciation)
1,737.09
0
1,737.09
Operating Profit (PBDIT) excl Other Income
224.92
0.00
224.92
Other Income
54.34
0
54.34
Operating Profit (PBDIT)
386.59
0
386.59
Interest
34.59
0
34.59
Exceptional Items
0.70
0
0.70
Gross Profit (PBDT)
565.93
0
565.93
Depreciation
144.10
0
144.10
Profit Before Tax
208.60
0
208.60
Tax
23.87
0
23.87
Provisions and contingencies
0
0
0.00
Profit After Tax
183.74
0
183.74
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
183.74
0
183.74
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
183.74
0
183.74
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
6,300.14
0
6,300.14
Earnings per share (EPS)
0.88
0
0.88
Diluted Earnings per share
0.88
0
0.88
Operating Profit Margin (Excl OI)
9.59%
0%
0.00
9.59%
Gross Profit Margin
17.98%
0%
0.00
17.98%
PAT Margin
9.36%
0%
0.00
9.36%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 196.20 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 16.73% vs -2.22% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 18.37 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -16.31% vs 11.20% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 33.23 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -6.94% vs -6.22% in Dec 2024
Annual - Interest
Interest 3.46 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -44.46% vs -8.65% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 9.59%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has fallen from Dec 2024






